We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pernix Web Page Draws Untitled Letter for Questionable Product Claims
Pernix Web Page Draws Untitled Letter for Questionable Product Claims
Pernix Therapeutics’ promotional webpage for its bronchitis drug Cedax has drawn an untitled letter from the FDA for making misleading claims and omitting risk information.